The European Cancer Summit, organised by the European Cancer Organisation (ECO) brings together leading oncology experts, experienced patient advocates, key opinion leaders, policymakers and politicians to discuss key issues in reducing the burden of cancer, saving, and improving the lives of patients and the public.
This year, the European Cancer Summit 2023 which will take place through November 15-16, 2023 in Brussels, Belgium will showcase multi-stakeholder,
At this pivotal moment in European legislation, and as we approach the European Parliament Elections in 2024, the World Bladder Cancer Patient Coalition and the European Association of Urology are excited to host a policy roundtable for the launch of the White Paper on Bladder Cancer.
We are honored to have MEP István Ujhelyi as our host for the event which will take place on September 25, 2023, from 15:00 to 16:30 CEST in room 5G305 at the European Parliament in Brussels,
Last October, The World Bladder Cancer Patient Coalition joined for the first time the World Cancer Congress 2022. Organized in Geneva, Switzerland, by the Union for International Cancer Control (UICC), the Congress welcomed 2000+ participants from over 120 countries for the first time since 2018.
WBCPC Executive Director, Alex Filicevas, joined a digital panel discussion titled “Empowering genitourinary cancer patients to become their own best advocates.” Organized by the European Association of Urology and co-developed by WBCPC,
On December 7, 2022, Alex Filicevas, Executive Director of the World Bladder Cancer Patient Coalition, co-chaired a joint event in the European Parliament on the challenge of urinary problems faced by people living with prostate and bladder cancer.
The event was a collaboration between the European Cancer Organisation, European Association of Urology, European Association of Urology Nurses – EAUN, World Federation of Incontinence and Pelvic Problems,
Alex Filicevas, Executive Director of the World Bladder Cancer Patient Coalition, joined a panel discussion at The Economist’s 8th Annual World Cancer Series: Europe, which took place in person on November 8 – 9, 2022, in Brussels, Belgium.
The 8th World Cancer Series: Europe 2022 focused on ”innovation, equity and excellence”. It explored different strategies to accelerate innovation, reduce inequities across cancer control in Europe, and what could to done to build towards universally excellent cancer control and cancer outcomes across the continent.
The World Bladder Cancer Patient Coalition joined for the first time the World Cancer Congress 2022. Organised in Geneva, Switzerland, by the Union for International Cancer Control (UICC), the Congress welcomed 2000+ participants from over 120 countries for the first time since 2018.
The WBCPC delegation included President Dr Lydia Makaroff and Executive Director Alex Filicevas, focusing on connecting with patient advocates, civil society groups and cancer control leaders from around the world.
The European Cancer Summit, organised by the European Cancer Organisation (ECO) brings together leading oncology experts, experienced patient advocates, key opinion leaders, policymakers and politicians to discuss key issues in reducing the burden of cancer, saving, and improving the lives of patients and the public.
This year, the European Cancer Summit 2022 which will take place through November 16-17, 2022 in Brussels, Belgium will focus on the implementation of Europe’s Beating Cancer Plan and the EU Cancer Mission’s ambitions and recommendations,
Lydia Makaroff, World Bladder Cancer Patient Coalition (WBCPC) President, represented the organisation at the World Health Organization’s Informal consultation with people living with non-communicable diseases (PLWNCDs) and mental health conditions (MHCs) to highlight the importance of including people with lived experiences in co-designing policies, programs, and principles.
The consultation supports the co-creation of the engagement framework and explored the importance of how meaningful engagement of PLWNCDs and MHCs is and can be further implemented at a regional and national level.
The Global Cancer Coalitions Network hosted its second “Coalition Connection 2: COVID19 Vaccines & Cancer” virtual event on November 23. The event was moderated by Alex Filicevas, Executive Director of the World Bladder Cancer Patient Coalition.
Formed in the wake of COVID-19, the Global Cancer Coalition Network is a collaboration of nine global cancer coalitions and alliances, representing 750 patient organisations working on behalf of 14 million cancer patients around the world.
The World Bladder Cancer Patient Coalition (WBCPC) joined two separate panel discussions at The Economist’s 7th Annual World Cancer Series: Europe which took place virtually on November 8-11, 2021.
The 7th World Cancer Series: Europe 2021 explored what needs to be done to catalyse a “triple bottom line” for Europe: better cancer outcomes, sustainable cancer care, and social and economic growth and development. And how this can impact cancer care beyond the region.